30
Participants
Start Date
September 16, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Alvesco Inhalant Product
Inhaled Alvesco will be administered daily for 14 days at escalating doses of 80mcg and 160mcg.
RECRUITING
Children's Mercy Kansas City, Kansas City
University of Pittsburgh
OTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Children's Mercy Hospital Kansas City
OTHER